We serve Chemical Name:3,4-Dichloro-5-nitropyridine CAS:56809-84-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,4-Dichloro-5-nitropyridine
CAS.NO:56809-84-8
Synonyms:3-Nitro-4,5-dichlorpyridin;3,4-dichloro-5-nitro-pyridine;Pyridine,3,4-dichloro-5-nitro;3,4-Dichloro-5-nitro-pyridin
Molecular Formula:C5H2Cl2N2O2
Molecular Weight:192.98800
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:258.751ºC at 760 mmHg
Density:1.63g/cm3
Index of Refraction:1.603
PSA:58.71000
Exact Mass:191.94900
LogP:2.81980
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Nitro-4,5-dichlorpyridin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,4-Dichloro-5-nitro-pyridin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-dichloro-5-nitro-pyridine Use and application,3,4-dichloro-5-nitro-pyridine technical grade,usp/ep/jp grade.
Related News: An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. 3,4-Dichloro-5-nitropyridine manufacturer The Ministry of Agriculture said late Saturday that a fresh outbreak of a lethal form of influenza had been found in poultry in the southern province of Hunan, and that officials had ordered the slaughter of 17,828 chickens. 3,4-Dichloro-5-nitropyridine supplier The Ministry of Agriculture said late Saturday that a fresh outbreak of a lethal form of influenza had been found in poultry in the southern province of Hunan, and that officials had ordered the slaughter of 17,828 chickens. 3,4-Dichloro-5-nitropyridine vendor At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content. 3,4-Dichloro-5-nitropyridine factory A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters.
